Related Experiment Video
Updated: Jun 19, 2026

07:13
An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
Published on: December 7, 2016
Bleb Revision Techniques for Hypotony Maculopathy: A Review
Ke Zeng1, Huda Sheheitli2, Astrid Werner1
1Department of Ophthalmology, Tufts Medical Center, Boston, MA.
International Ophthalmology Clinics
|June 18, 2026
Summary
Hypotony maculopathy after glaucoma surgery can cause vision loss. This review explores current nonsurgical and surgical treatments, emphasizing tailored approaches due to the lack of a gold standard.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Glaucoma Surgery
Background:
- Hypotony maculopathy, marked by chorioretinal folds, is a complication of trabeculectomy, potentially leading to vision loss.
- The incidence of hypotony maculopathy has risen with the use of antifibrotic agents in glaucoma surgery.
- Managing hypotony maculopathy requires balancing the need to increase intraocular pressure to treat the condition with the necessity of maintaining low pressure to control glaucoma.
Purpose of the Study:
- To review nonsurgical and surgical management strategies for hypotony maculopathy.
- To discuss the challenges in treating hypotony maculopathy, particularly the delicate balance of intraocular pressure.
- To highlight the importance of individualized treatment selection based on patient and bleb characteristics.
Main Methods:
- Literature review of nonsurgical and surgical interventions for hypotony maculopathy.
- Analysis of treatment outcomes and challenges.
- Synthesis of current evidence regarding management options.
Main Results:
- A range of nonsurgical and surgical options exist for hypotony maculopathy.
- No definitive gold standard treatment has been established for hypotony maculopathy.
- Treatment selection is contingent upon individual patient factors and the characteristics of the filtering bleb.
Conclusions:
- Effective management of hypotony maculopathy necessitates a personalized approach.
- Further research is needed to establish a gold standard treatment protocol.
- Careful consideration of patient-specific and surgical factors is crucial for optimizing outcomes in hypotony maculopathy.

